Open house Arzneimittelrabattverträge Ertugliflozin, ATC A10BK04

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 583 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Structured notice only

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ertugliflozin, ATC A10BK04

30/100

Score d'opportunité

Needs reviewLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

30 / 100

Complexité

20 / 100

Facteurs de risque

No guaranteed volume or minimum purchase; participation may not be commercially viable.

Monthly submission deadline for quick start: documents must be in by 3rd of month to start next month.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until May 2028
Supply of Ertugliflozin (ATC A10BK04) under non-exclusive discount agreements
Non-exclusive, open-to-all model; no competition or selection

Afficher le résumé complet

This is an open-house (non-procurement) model for non-exclusive drug discount agreements for Ertugliflozin (ATC A10BK04) with AOK Bayern. All eligible pharmaceutical companies can join on identical terms. Contracts run from June 2026 to May 2028, with possible conclusion anytime until April 2028. No estimated value is provided. Only a signed declaration of reliability is required. The procedure is not subject to procurement law.

Risques

No guaranteed volume or minimum purchase; participation may not be commercially viable.

Monthly submission deadline for quick start: documents must be in by 3rd of month to start next month.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible

Certifications

Documents must be in German or accompanied by a certified German translation

Administrative

Submit signed contract, completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability

Les exigences peuvent être incomplètes.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Ertugliflozin, ATC A10BK04

Non-exclusive discount agreements for the active substance Ertugliflozin (ATC A10BK04). All eligible pharmaceutical companies may join. Contracts are identical and not individually negotiable. Performance in Bavaria, Germany.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2026 - May 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Apr 03, 2028

Détails de la procédure

Date de publication: 14 Apr 2026
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 257130-2026

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3